Pay in 4 interest-free payments of $6.66 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Zepbound contains Tirzepatide and follows similar obesity treatment criteria
Cellular Bioenergetics and Metabolic Physiology Efficient mitochondrial function is essential for maintaining normal cellular activity, particularly in tissues with high energy demands such as skeletal muscle, cardiac muscle, and the liver
Recently, the GIP/GLP-1R co-agonist tirzepatide has gone through several randomized controlled trials and was approved by the FDA for T2DM and obesity in 2022 and 2023, respectively
Offering convenient semaglutide telehealth visits, we make it effortless to start your weight loss journey from the comfort of your home
Patients Lost 31LBS on Average In a trial with 1,387 patients who were obese but did not have Type 2 diabetes, patients were randomly assigned to different doses of Semaglutide
Initial Dose : The starting dose is typically 0.25 mg once weekly
